ID3 and cancer: In cancer cachexia however, where treatment of proliferating myoblasts with conditioned medium from the PC3 tumour is known to transiently upregulate C/EBPβ expression and to inhibit myogenic differentiation28, knockdown of ID3 rescues both differentiation and fusion.